Vasa vasorum imaging: A new window to the clinical detection of vulnerable atherosclerotic plaques

Current Atherosclerosis Reports

Volumn 7, Issue 2, 2005, Pages 164-169

  Carlier, Stéphanie ^b   Kakadiaris, Ioannis A ^b   Dib, Nabil ^b   Vavuranakis, Manolis ^b   Stefanadis, Christodoulos ^b   O'Malley, Sean M ^b   Hartley, Craig J ^b   Metcalfe, Ralph ^b   Mehran, Roxana ^b   Falk, Erling ^b   Gul, Khawar ^b   Naghavi, Morteza ^a  

^a AEHA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROTIC PLAQUE; CONTRAST ENHANCEMENT; DENSITY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; HEART INFARCTION; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERNET; INTRAVASCULAR ULTRASOUND; MEDICAL ASSESSMENT; MICROBUBBLE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SPECTROSCOPY; STROKE; THERMOGRAPHY; VASA VASORUM;

EID: 20144388343     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-005-0040-2     Document Type: Review

References (38)

1. Naghavi M, Libby P, Falk E, et al.: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108: 1664-1672.
2. Naghavi M, Libby P, Falk E, et al.: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003, 108: 772-1778.
3. Carlier SG, De Korte CL, Brusseau E, et al.: Elastography. J Cardiovasc Risk 2002, 9:237-245.
4. Nair A, Kuban BD, Tuzcu EM, et al.: Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 2002, 106:2200-2206.
5. Kawasaki M, Takatsu H, Noda T, et al.: In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation 2002, 105: 487-2492.
6. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ: Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984, 310:175-177.
7. Moulton KS, Vakili K, Zurakowski D, et al.: Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci 2003, 8:4736-4741.
8. Moreno PR, Purushothaman KR, Fuster V, O'Connor WN: Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: Implications for plaque vulnerability. Circulation 2002, 105:2504-2511.
9. Moreno PR, Purushothaman KR, Fuster V, et al.: Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004, 110:2032-2038.
10. Fleiner M, Kummer M, Mirlacher M, et al.: Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 2004, 110:2843-2850.
11. Kolodgie FD, Gold HK, Burke AP, et al.: Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003, 349:2316-2325.
12. Mazurek T, Zhang L, Zalewski A, et al.: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
13. Litovsky S, Vela D, Burke A, et al.: Periadventitial fat inflammation may be a novel marker of plaque vulnerability. In press.
14. Gossl M, Malyar NM, Rosol M, et al.: Impact of coronary vasa vasorum functional structure on coronary vessel wall perfusion distribution. Am J Physiol Heart Circ Physiol 2003, 285:H2019-H2026.
15. Wilson SH, Herrmann J, Lerman LO, et al.: Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 2002, 105:415-418.
16. Winter PM, Morawski AM, Caruthers SD, et al.: Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003, 108:2270-2274.
17. Moulton KS, Heller E, Konerding MA, et al.: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999, 99:1726-1732.
18. Yuk IH, Olsen MM, Geyer S, Forestell SP: Perfusion cultures of human tumor cells: a scalable production platform for oncolytic adenoviral vectors. Biotechnol Bioeng 2004, 86: 37-642.
19. Weber MA, Thilmann C, Lichy MP, et al.: Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol 2004, 39:277-287.
20. Padhani AR, Dzik-Jurasz A: Perfusion MR imaging of extracranial tumor angiogenesis. Top Magn Reson Imaging 2004, 15:41-57.
21. Kaul S: Instrumentation for contrast echocardiography: technology and techniques. Am J Cardiol 2002, 90:8J-14J.
22. Stewart M: Contrast echocardiography. Heart 2003, 89:342-348.
23. Feinstein SB: The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol 2004, 287: 450-H457.
24. Lanza GM, Wickline SA: Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 2001, 44:13-31.
25. Hamilton AJ, Huang SL, Warnick D, et al.: Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol 2004, 43:453-460.
26. Lee TY, Purdie TG, Stewart E: CT imaging of angiogenesis. J Nucl Med 2003, 47:171-187.
27. Yuan C, Kerwin WS, Ferguson MS, et al.: Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002, 15: 2-67.
28. Dijkstra J, Koning G, Reiber JH: Quantitative measurements in IVUS images. Int J Card Imaging 1999, 15:513-522.
29. Klingensmith JD, Shekhar R, Vince DG: Evaluation of three-dimensional segmentation algorithms for the identification of luminal and medial-adventitial borders in intravascular ultrasound images. IEEE Trans Med Imag 2000, 19:1996-1011.
30. von Birgelen C, de Vrey EA, Mintz GS, et al.: ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of an automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation 1998, 96:2944-2952.
31. Zhu H, Oakeson KD, Friedman MH: Retrieval of cardiac phase from IVUS sequences. Proc SPIE Med Imaging: Ultrasonic Imaging and Signal Processing, 2003, 47:135-146.
32. Cachard C, Finet G, Bouakaz A, et al.: Ultrasound contrast agent in intravascular echography: an in vitro study. Ultrasound Med Biol 1997, 23:705-717.
33. Lindner JR, Song J, Xu F, et al.: Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 2000, 102:2745-2750.
34. Hartley CJ, Cheirif J, Collier KR, et al.: Doppler quantification of echo-contrast injections in-vivo. Ultrasound Med Biol 1993, 19:269-278.
35. Gossl M, Rosol M, Malyar NM, et al.: Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries. Anat Rec 2003, 272A:526-537.
36. Casscells W, Hassan K, Vaseghi MF, et al.: Plaque blush, branch location, and calcification are angiographic predictors of progression of mild to moderate coronary stenoses. Am Heart J 2003, 145:813-820.
37. Kerwin W, Hooker A, Spilker M, et al.: Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003, 107:851-856.
38. Tom EM, Lu E, Felix MM, Varghese R: In vivo microbubble binding to inflammatory endothelium via selectin targeting by Sialyl Lexis X. Program and abstracts from the American College of Cardiology 53rd Annual Scientific Session. New Orleans, Louisiana, 2004:1001-1033.